- Home
- WTBA vs MYGN Comparison
WTBA vs MYGN Comparison
Compare WTBA & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WTBA | MYGN |
|---|---|---|
| Founded | 1893 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.4M | 444.2M |
| IPO Year | 2002 | 1996 |
Fundamental Metrics
Financial Performance| Metric | WTBA | MYGN |
|---|---|---|
| Price | $27.27 | $5.61 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $24.00 | $7.64 |
| AVG Volume (30 Days) | 73.9K | ★ 1.3M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.17% | N/A |
| EPS Growth | ★ 35.21 | N/A |
| EPS | ★ 1.26 | N/A |
| Revenue | N/A | ★ $771,400,000.00 |
| Revenue This Year | $23.80 | $6.86 |
| Revenue Next Year | $9.39 | $5.45 |
| P/E Ratio | $21.58 | ★ N/A |
| Revenue Growth | N/A | ★ 2.33 |
| 52 Week Low | $17.50 | $3.53 |
| 52 Week High | $27.87 | $8.59 |
Technical Indicators
Market Signals| Indicator | WTBA | MYGN |
|---|---|---|
| Relative Strength Index (RSI) | 62.29 | 50.47 |
| Support Level | $22.89 | $5.57 |
| Resistance Level | $27.74 | $6.34 |
| Average True Range (ATR) | 0.83 | 0.29 |
| MACD | -0.03 | -0.10 |
| Stochastic Oscillator | 82.77 | 3.51 |
Price Performance
Historical ComparisonAbout WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings, and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.